Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.
Saved in:
| Title: | Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy. |
|---|---|
| Authors: | Santacana Juncosa E; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain., Rodríguez-Alonso L; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Padullés Zamora A; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain., Guardiola J; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Rodríguez-Moranta F; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Serra Nilsson K; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Bas Minguet J; Immunology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Morandeira Rego F; Immunology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain., Colom Codina H; Pharmacy and Pharmaceutical Technology Department, Universitat de Barcelona-UB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain., Padullés Zamora N; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Feb; Vol. 87 (2), pp. 494-505. Date of Electronic Publication: 2020 Jun 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32495380 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Santacana+Juncosa+E%22">Santacana Juncosa E</searchLink>; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Alonso+L%22">Rodríguez-Alonso L</searchLink>; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padullés+Zamora+A%22">Padullés Zamora A</searchLink>; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Guardiola+J%22">Guardiola J</searchLink>; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Moranta+F%22">Rodríguez-Moranta F</searchLink>; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Serra+Nilsson+K%22">Serra Nilsson K</searchLink>; Department of Gastroenterology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bas+Minguet+J%22">Bas Minguet J</searchLink>; Immunology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Morandeira+Rego+F%22">Morandeira Rego F</searchLink>; Immunology, Hospital Universitari de Bellvitge-HUB. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Colom+Codina+H%22">Colom Codina H</searchLink>; Pharmacy and Pharmaceutical Technology Department, Universitat de Barcelona-UB, Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Padullés+Zamora+N%22">Padullés Zamora N</searchLink>; Department of Pharmacy, Hospital Universitari de Bellvitge-HUB. Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Program, Institut d'Investigació Biomèdica de Bellvitge-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2021 Feb; Vol. 87 (2), pp. 494-505. <i>Date of Electronic Publication: </i>2020 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32495380 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.14410 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 494 Titles: – TitleFull: Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Santacana Juncosa E – PersonEntity: Name: NameFull: Rodríguez-Alonso L – PersonEntity: Name: NameFull: Padullés Zamora A – PersonEntity: Name: NameFull: Guardiola J – PersonEntity: Name: NameFull: Rodríguez-Moranta F – PersonEntity: Name: NameFull: Serra Nilsson K – PersonEntity: Name: NameFull: Bas Minguet J – PersonEntity: Name: NameFull: Morandeira Rego F – PersonEntity: Name: NameFull: Colom Codina H – PersonEntity: Name: NameFull: Padullés Zamora N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 87 – Type: issue Value: 2 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |